狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            上海起發(fā)實(shí)驗(yàn)試劑有限公司

            線性聚乙烯亞胺PEI,硫酸葡聚糖 DSS

            化工儀器網(wǎng)收藏該商鋪

            16

            聯(lián)系電話

            15921799099

            您所在位置:
            上海起發(fā)實(shí)驗(yàn)試劑有限公司>>品牌介紹>> NIBSC標(biāo)準(zhǔn)品產(chǎn)品代理
             QQ交談
            產(chǎn)品展示

            NIBSC標(biāo)準(zhǔn)品產(chǎn)品代理

            • 公司名稱:
            • 更新時(shí)間:
            • 所 在 地:
            • 生產(chǎn)地址:
            • 瀏覽次數(shù):
            • 上海起發(fā)實(shí)驗(yàn)試劑有限公司
            • 2024-08-29 12:08:21
            • 上海市
            • 6297

            我要詢價(jià)

            【簡(jiǎn)單介紹】

            英國國家生物制品檢定所是WHO的一個(gè)標(biāo)準(zhǔn)品供應(yīng)中心實(shí)驗(yàn)室,它的核心工作是制備、保存和分發(fā)WHO用于檢測(cè)生物制品質(zhì)量的標(biāo)準(zhǔn)品。NIBSC制備的流感毒株和檢測(cè)抗原、抗血清標(biāo)準(zhǔn)品,保障了各廠家順利的研究和生產(chǎn)。

            【詳細(xì)說明】

             

             英國國家生物制品檢定所(National Institute for Biological Standards and Control,NIBSC)

             

              英國國家生物制品檢定所是WHO的一個(gè)標(biāo)準(zhǔn)品供應(yīng)中心實(shí)驗(yàn)室,它的核心工作是制備、保存和分發(fā)WHO用于檢測(cè)生物制品質(zhì)量的標(biāo)準(zhǔn)品。NIBSC制備的流感毒株和檢測(cè)抗原、抗血清標(biāo)準(zhǔn)品,保障了各廠家順利的研究和生產(chǎn)。

             

              NIBSC提供對(duì)投入英國市場(chǎng)的生物藥品的獨(dú)立測(cè)試,尤其是用于英國兒童免疫計(jì)劃的疫苗;它同時(shí)也是歐盟控制藥品進(jìn)入歐盟市場(chǎng)的*藥品控制實(shí)驗(yàn)室(OMCL)。 如果出現(xiàn)不能滿足藥品存放要求或患者出現(xiàn)不良反應(yīng)等問題,NIBSC 也可對(duì)已投入歐盟市場(chǎng)的產(chǎn)品進(jìn)行檢驗(yàn)。

             

              NIBSC認(rèn)為對(duì) NIBSC工作的核心職能制定并維護(hù)一項(xiàng)既均衡而又主次分明的計(jì)劃至關(guān)重要??刂坪驮u(píng)估生物藥品。開發(fā)和提供關(guān)鍵的生物學(xué)標(biāo)準(zhǔn)和其它參考資料。開展針對(duì)任務(wù)的研究和開發(fā)工作。

            Streptokinase 00/464
            Interferon Beta (Human, rDNA; CHO cell-derived; Glycosylated) 00/572
            Interferon Beta Ser 17 Human, recDNA, E-coli-derived, non-glycosylated 00/574
            Interferon Beta, Human, Fibroblast Cell-Derived, Glycosylated 00/576
            Interleukin-17 Human rec DNA 01/420
            Vascular Endothelial Growth Factor, Human rDNA derived 01/424
            Botulinum Antitoxin Equine Type D 01/510
            Anti-D Immunoglobulin 01/572
            Thrombin, human, 2nd International Standard 01/580
            Low Molecular Weight Heparin, 2nd International Standard 01/608
            Blood Coagulation Factor VIII Concentrate, Human 02/122
            Prekallikrein Activator (PKA), Human 02/168
            Blood Coagulation Factor XIII, Plasma, Human 1st IS 02/206
            IVIG negative control for use with IVIG + anti-D 02/226
            IVIG + anti-D for use with negative control IVIG 02/228
            Vascular Endothelial Growth Factor 02/286
            Blood Coagulation Factor V, Plasma(1st I.S.) 03/116
            Thrombopoietin, human rDNA derived 03/124
            Keratinocyte growth factor (KGF, FGF-7)(24-163) 03/148
            Keratinocyte Growth Factor (KGF,FGF-7) 03/150
            Thyroid Stimulating Hormone, recombinant 03/192
            Interleukin - 18 (Human rDNA derived) 03/200
            IVIG + Anti-D for use with negative control IVIG 04/132
            IVIG Negative Control for use with IVIG & Anti-D 04/140
            TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived 04/166
            Parathyroid hormone 1-34 Recombinant, Human 04/200
            Protein C Concentrate, Human 04/252
            Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard). 05/112
            Alpha-1-Antitrypsin, plasma derived 05/162
            IVIG, Anti-D and Negative Control Panel 05/242
            Antithrombin Concentrate, Human 06/166
            FEIBA Concentrate 1st NIBSC Working Reference Standard 06/172
            Blood Coagulation Factor IX Concentrate, Human, 4th International Standard” 07/182
            Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” 07/228
            Anti-D for assuring operator and test performance 07/304
            Anti-A and Anti-B in IVIG Positive Control 07/306
            Anti-A and Anti-B in IVIG Negative Control 07/308
            Anti-A and anti-B in IVIG: Limit reference preparation 07/310
            Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.) 07/316
            Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard. 07/326
            Unfractionated Heparin (6th I.S.) 07/328
            Blood Coagulation Factor VIII Concentrate (8th I.S.) 07/350
            Chorionic Gonadotrophin, (5th International Standard) 07/364
            Streptodornase (2nd International Standard) 08/230
            C1- Inhibitor, Concentrate (1st International Standard) 08/256
            Anti-A and Anti-B in IVIG: Positive and Negative control panel. (2 ampoules of 07/306 and 2 ampoules of 07/308) 08/270
            Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard) 08/282
            Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard) 09/136
            VWF Factor Concentrate (2nd International Standard) 09/182
            Corticotrophin (ACTH), Porcine 59/016
            Serum Gonadotrophin, Equine 62/001
            Lysine Vasopressin, Porcine 62/014
            Renin, Porcine 65/119
            Gastrin II, Porcine 66/138
            Interferon, Chick 67/018
            Renin, Human 68/356
            Glucagon, Porcine 69/194
            Angiotensin II 70/302
            Angiotensin I 71/328
            Corticotrophin (ACTH), Human 74/555
            Ancrod 74/581
            Blood Coagulation Factor Xa, Bovine 75/595
            Oxytocin 76/575
            Lysine Vasopressin 77/512
            Secretin 77/643
            Kininogenase, Porcine 78/543
            Luteinizing Hormone, Pituitary, alpha subunit 78/554
            Luteinizing Hormone, Pituitary, beta subunit 78/556
            Prekallikrein Activator (PKA), Human 79/572
            Growth Hormone, Human, Pituitary 80/505
            Luteinizing Hormone, Human, Pituitary 80/552
            Tetracosactide 80/590
            Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment 82/508
            Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment 82/512
            Interferon Gamma (Human, Leukocyte derived) 82/587
            Parathyroid Hormone, Bovine 82/632
            Insulin, Human 83/500
            Beta Thromboglobulin, Purified Human 83/501
            Plaet Factor 4 Human, Purified 83/505
            Insulin, Bovine 83/511
            Interferon alpha-1D, (Human rDNA derived) 83/514
            Insulin, Porcine 83/515
            Prolactin, Human 83/573
            Follicle Stimulating Hormone, Pituitary 83/575
            Prolactin, Human 84/500
            Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) 84/614
            C-Reactive Protein, Human 85/506
            Atrial Natriuretic Factor, Human 85/669
            Interleukin-2 (Human, Jurkat derived) 86/504
            Angiotensin I Human Type Synthetic 86/536
            Angiotensin II 86/538
            Interleukin-1 Beta (Human, rDNA derived) 86/552
            Interleukin-2 (Human, rDNA derived) 86/564
            Interleukin-1 alpha (Human rDNA derived) 86/632
            Interleukin-1 alpha (Human, rDNA derived) 86/678
            Interleukin-1 beta (Human, rDNA derived) 86/680
            Inhibin, Porcine 86/690
            Interferon Gamma (Human, rDNA derived) 87/586
            Urokinase, High Molecular Weight 87/594
            Tumour Necrosis Factor beta (Human, rDNA derived) 87/640
            Tumour Necrosis Factor alpha (Mouse, rDNA derived) 88/532
            Calcitonin, Eel 88/556
            Erythropoietin, Human recombinant 88/574
            Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) 88/646
            Interleukin-4 (Human, rDNA derived) 88/656
            Tumour Necrosis Factor alpha (Human Natural) 88/786
            Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) 89/512
            Transforming Growth Factor beta-1 (Human, rDNA derived) 89/514
            Transforming Growth Factor beta-1 (Bovine) 89/516
            Transforming Growth Factor beta-2 (Bovine) 89/518
            Interleukin-8 (Human, rDNA derived) 89/520
            Renin, Human, rec DNA 89/544
            Interleukin-6 (Human, rDNA derived) 89/548
            Calcitonin, Human 89/620
            Interleukin-7 (Human, rDNA derived) 90/530
            Interleukin-5 (Human, rDNA derived) 90/586
            Transforming Growth Factor beta-2, Human, rec DNA 90/696
            Basic Fibroblast Growth Factor (Human, rDNA derived) 90/712
            Interleukin-3 (Human, rDNA derived) 91/510
            Epidermal Growth Factor (Human, rDNA derived) 91/530
            Epidermal Growth Factor (1-52) (Human, rDNA derived) 91/550
            Insulin-like growth Factor 1 91/554
            Inhibin A, Human, recombinant 91/624
            Activin A, Human, Recombinant 91/626
            Interleukin-4 (Mouse, rDNA derived) 91/656
            Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived) 91/658
            Interleukin-3 (Mouse, rDNA derived) 91/662
            Interleukin-9 (Human,rDNA derived) 91/678
            Stem Cell Factor (Human rDNA derived) 91/682
            Follicle Stimulating Hormone, Human, recombinant 92/510
            Follicle Stimulating Hormone, urofollitropin Human Urinary 92/512
            Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived) 92/518
            Rantes (Human, rDNA derived) 92/520
            Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived) 92/644
            Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human 92/654
            Serum amyloid A protein 92/680
            Interleukin-11 (Human, rDNA derived) 92/788
            Monocyte Chemoattractant Protein-1 (Human,rDNA derived) 92/794
            Soluble Tumor Necrosis Receptor factor Type II (Human, rDNA derived) 93/524
            Batroxobin 93/526
            Nerve Growth Factor (Human, rDNA derived) 93/556
            Leukaemia Inhibitory Factor (Human, rDNA derived) 93/562
            Oncostatin M (Human, rDNA derived) 93/564
            Interleukin-2 (Mouse, rDNA derived) 93/566
            Bone morphogenetic Protein-2 (Human, rDNA derived) 93/574
            Interleukin-1 beta (Mouse, rDNA derived) 93/668
            Interleukin-1 alpha (Mouse, rDNA derived) 93/672
            Interleukin-10 (Human rDNA derived) 93/722
            Interleukin-6 (Mouse, rDNA derived) 93/730
            Interleukin-7 (Mouse, rDNA derived) 93/740
            Endotoxin 94/580
            Interleukin-13 (Human, rDNA derived) 94/622
            Ciliary Neurotrophic Factor (Human, rDNA derived) 94/684
            Straphylokinase, rec (STAR) 94/718
            Plaet-derived Growth Factor-BB (Human, rDNA derived) 94/728
            Tissue Plasminogen Activator (tPA) Antigen in Plasma 94/730
            Interferon Omega (Human, rDNA derived) 94/754
            Interferon alpha (Human, leukocyte derived) 94/784
            Interferon alpha Concensus Sequence (Human rDNA derived) 94/786
            Interleukin-12 (Human, rDNA derived) 95/544
            Interleukin-15 (Human, rDNA derived) 95/554
            Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc) 95/564
            Interferon alpha-2b (Human, rDNA derived) 95/566
            Interferon Alpha n1 (Human lymphoblastoid cell derived) 95/568
            Interferon alpha-1/8 (Human, rDNA derived) 95/572
            Interferon Alpha n3 (Human, leukocyte derived) 95/574
            Interferon alpha-2c (Human, rDNA derived) 95/580
            Interferon alpha-2a (Human, rDNA derived) 95/650
            Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc) 95/668
            Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived) 96/528
            FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) 96/532
            Brain-derived Neurotrophic Factor (Human, rDNA derived) 96/534
            Insulin-like growth Factor-II (Human rDNA derived) 96/538
            Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) 96/556
            Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) 96/564
            Luteinizing Hormone, Human, recombinant 96/602
            Inhibin B, Human 96/784
            Plasmin, Human 97/536
            Anti-Granulocyte Macrophage Colony Stimulating Factor Serum 97/538
            Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.) 97/562
            Blood Coagulation Factor VII Concentrate(1st I.S.) 97/592
            Leptin, Human, Recombinant 97/594
            Interleukin-2 Soluble Receptor (human, rDNA derived) 97/600
            Leptin, Mouse, Recombinant 97/626
            Somatropin 98/574
            Calcitonin, Salmon 98/586
            Blood Coagulation Factors II and X Concentrate(3rd I.S.) 98/590
            Transforming Growth Factor beta-3 (Human, rDNA derived) 98/608
            Fibrinogen, Plasma, Human, 2nd IS 98/612
            Fibrinogen Concentrate, Human, 1st International Standard 98/614
            Follicle Stimulating Hormone and Luteinizing Hormone, Human Urinary 98/704
            Tissue Plasminogen Activator, Human, Recombinant 98/714
            Neurotrophin 3 98/718
            Biotinylated Brad-5 (Bio-Brad-5) 99/698
            Anti-D Immunoglobulin Control 99/728
            Biotinylated Brad-5 99/774
            Thromboplastin,rabbit,plain(pack of 5 ampoules) with diluent (pack of 5 04/210) RBT/05
            Thromboplastin, Human Recombinant, Plain (4th I.S.) (Panel of 5 ampoules for use with 5 diluent 08/146). RTF/09


            Diagnostics
            Hepatitis A Virus RNA NAT Assays 00/560
            Hepatitis B Surface Antigen (HBsAg) subtype adw2, genotype A 00/588
            Hepatitis A Virus RNA Working Reagent for NAT assays 01/488
            Anti-Toxoplasma IgG, Human 01/600
            Anti-Parvovirus B19, plasma, human 01/602
            HIV (antibody), 1st International Reference Panel 02/210
            Insulin-like growth Factor I 02/254
            HCV RNA Working Reagent for Nucleic Acid Amplification Techniques 02/264-003
            Protein C Plasma 02/342
            HTLV-1 (antibody) Monitor Sample 03/104-009
            Anti-HPA-1a standard 03/152
            Anti-B minimum potency reference preparation 03/164
            Vitamin B12, Serum Folate 03/178
            Anti-A minimum potency reference preparation 03/188
            Anti-HPA-3a(minimum potency) 03/190
            Protein S, Plasma, Human 03/228
            Hepatitis B Surface Antigen subtype adw2, genotype A Reference Panel 03/262
            QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample1 03/B346-06
            Blood Coagulation Factor XI Plasma, Human(1st I.S.) 04/102
            Plasmodium falciparum DNA for NAT Assays 04/176
            Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 04/224
            Anti-HPA-1a minimum potency reagent 05/106
            Anti-syphilis plasma IgG (human) 05/122
            Prothrombin Mutation G20210A, Human gDNA, 1st International Genetic Reference Panel 2005 05/130
            Anti-syphilis plasma IgG and IgM (human) 05/132
            HIV-1 RNA Working Reagent 3 for NAT Assays 05/158-002
            HLA-A Genotyping Reference Panel. 05/208-001
            QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1 05/B433-06
            Hepatitis C Virus (HCV) RNA 06/100
            Anti Hepatitis C Virus 06/188-006
            Anti-HCV (1 in 8 dilution) 06/190-008
            HPV 16 DNA 06/202
            HPV 18 DNA 06/206
            QCRHIV1QC5-Anti-HIV1: Quality Control Serum: Sample5 06/B461-04
            QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 06/B475-06
            Anti-HBs immunoglobulin 07/164
            Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent) 07/202
            Positive control for FCXM 07/214
            RhD/SRY Plasma DNA sensitivity standard 07/222
            Hepatitis B Surface Antigen Monitor Sample 07/286-006
            Hepatitis B Surface Antigen 0.2IU/ml 07/288-004
            Norovirus GII for Nucleic Acid Amplification Techniques 07/294-001
            Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques 07/296-001
            Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques 07/298-001
            Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques 07/300-001
            QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 07/B498-08
            QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample1 07/B506-09
            QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 07/B506-11
            QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 07/B512-06
            QCRHBsQC1-Anti HBs Quality Control Serum: Sample1 07/B515-06
            QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 07/B519-12
            Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques 08/114-001
            Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques 08/118-001
            Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques 08/120-001
            HIV-2 RNA(1st International Standard) 08/150
            Fragile X Syndrome gDNA Genetic Reference Panel 08/158
            Haemophilia A, Intron-22 inversion, gDNA, Genetic Reference Panel 08/160
            Human Coxsackie B4 for Nucleic Acid Amplification Techniques 08/174-001
            Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques 08/176-001
            Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques 08/178-001
            Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques 08/180-001
            Thyroid Stimulating Antibody (2nd I.S.) 08/204
            Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques 08/224-001
            Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques 08/226-001
            Antithrombin, Plasma (3rd International Standard) 08/258
            C1 Inhibitor (Plasma)(1st International Standard) 08/262
            HCV RNA Genotype Panel for Nucleic acid amplification techniques 08/264
            Sex Hormone Binding Globulin. (2nd International Standard) 08/266
            Varicella Zoster Virus (Type B) Working Reagent for Nucleic Acid Amplification Testing (NAT) 08/310-001
            Human Cytomegalovirus for Nucleic Acid Amplification Techniques 08/314-002
            Epstein-Barr Virus for Nucleic Acid Amplification Techniques 08/316-001
            Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing 08/318-001
            Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing 08/320-001
            Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing 08/322-001
            Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing 08/324-001
            HIV-1RNA Genotype Panel 08/358
            QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1 08/B523-03
            QCRVZVQC1-AntiVZV: Quality Control Serum: Sample1 08/B531-06
            QCRHIV2QC3-Anti HIV2: Quality Control Serum: Sample3 08/B534-03
            QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 08/B536-05
            QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 08/B538-04
            QCRNEGQC1-Negative Quality Control Serum: Sample1 08/B539-06
            QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 08/B542-06
            QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2 08/B544-06
            QCRCMVQC1-Anti CMV: Quality Control Serum: Sample1 08/B549-06
            QCRHBeQC1-Anti-HBe Quality Control Serum: sample1 08/B554-04
            Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard) 09/110
            Negative Control for FCXM 09/112
            Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing 09/132-001
            Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.) 09/138
            Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel) 09/140
            Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard) 09/162
            Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard) 09/172
            Neisseria meningitidis for Nucleic Acid Amplification Testing (NAT) 09/320-001
            QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2 09/B559-06
            QCRHIV1QC3- Anti-HIV1:Quality Control Serum: Sample3 09/B562-01
            QCRHBsGQC1-Anti HBsAg Quality Control Serum: Sample1 09/B564-02
            QCRHBsGQC2-Anti HBsAg Quality Control Serum: Sample2 09/B566-01
            QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2 09/B571-02
            QCRHAVIgMQC2-Anti-HAV Quality Control Serum: Sample2 09/B572-05
            QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1 09/B577-01
            QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 09/B584-01
            QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 09/B585-03
            QCRHBsQC1-Anti HBs Quality Control Serum: Sample1 09/B587-02
            HBV DNA PCR Reference 10/194-001
            Rheumatoid Arthritis Serum 64/002
            Anti-Thyroglobulin Serum, Human 65/093
            Long-acting Thyroid Stimulator, Human 65/122
            Anti-Nuclear Factor Serum (Homogenous) Human 66/233
            Insulin, Human 66/304
            Anti-thyroid Microsome Serum, Human 66/387
            Immunoglobulin D (IgD) Serum, Human 67/037
            Immunoglobulins G, A, M Serum Human 67/086
            Immunoglobulins G, A & M Serum Human 67/099
            Primary Biliary Cirrhosis Serum, Human 67/183
            Erythropoietin, Human, Urinary 67/343
            Anti-Nucleolar Factor Plasma, Human 68/340
            Autoimmune Antibody to Human Spermatazoa 69/065
            Anti-D (Rho) Antibodies, Human 73/515
            Placental Lactogen, Human 73/545
            Carcinoembryonic Antigen (CEA), Human 73/601
            Serum Proteins (Other than Immunoglobulins) Human 74/520
            Corticotrophin (ACTH), Porcine 74/586
            Serum Immunoglobulin E (IgE) Human 75/502
            Cocksfoot Pollen Extract 75/506
            Chorionic Gonadotrophin, Human, for Radioiodination 75/533
            Chorionic Gonadotrophin beta, Human, for Radioiodination 75/535
            Parathyroid Hormone, Human 75/549
            Chorionic Gonadotrophin beta Subunit, Human 75/551
            Chorionic Gonadotrophin alpha subunit, Human 75/569
            Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination 76/508
            Mannan (C. Albians) Purified 76/515
            Anti-Birch Pollen Serum, Human 76/525
            Anti-Cocksfoot Serum, Human 77/503
            Anti-D Pteronyssinus Serum, Human 77/584
            Mannan (C. Albicans) Purified 77/600
            Twelve Grass Pollen Extract 77/616
            Acarus Siro Extract 77/662
            Glycyphagus destructor Extract 77/664
            Tyrophagus Putrescentiae Extract 78/517
            Anti-Aspergillus fumigatus Serum, Human 78/545
            Aspergillus Fumigatus Extract 78/575
            Tyrophagus Longior Extract 78/582
            Bee Venom 78/628
            Parathyroid Hormone, Human 79/500
            Anti-Cat Fur Serum, Human 79/530
            Thyroid Stimulating Hormone, Human 81/565
            Dermatophagoides Pteronyssinus Extract 82/518
            Timothy Pollen Extract 82/520
            Human Serum Vitamin B12, Pernicous anaemia 82/652
            C- Peptide of Human Insulin 84/510
            Proinsulin, Bovine 84/514
            Birch Pollen Extract 84/522
            Proinsulin, Porcine 84/528
            Short Ragweed Pollen Extract 84/581
            Proinsulin, Human 84/611
            Anti-c Serum, Human 84/628
            Dog (Canis Familiaris) Hair Dander Extract 84/685
            Thyroid Stimulating Hormone beta subunit 85/522
            Anti-Rye Grass Serum, Human 85/551
            Haemoglobin F Lysate, Raised 85/616
            Anti-Ferritin Monoclonal Antibody (1) 87/654
            Anti-Ferritin Monoclonal Antibody (2) 87/662
            Thyroxine-binding globulin 88/638
            Haemoglobin A2 Lysate, Raised 89/666
            HIV-1 P24 Antigen 90/636
            Anti-Varicella-Zoster Antibody 90/690
            Anti-D for use with papain preparation 92/658 91/562
            Papain preparation for use with Anti-D preparation 91/562 92/658
            Insulin-like growth Factor Binding Protein-3 93/560
            Ferritin, Human, recombinant 94/572
            Follicle Stimulating Hormone/Luteinizing Hormone, Human Pituitary 94/632
            Thyroid Stimulating Hormone, Human recombinant 94/674
            Anti-HBc (Anti-hepatitis B core antigen) 95/522
            Folate, Whole Blood 95/528
            Anti-hepatitis E Serum, Human 95/584
            Parathyroid Hormone 1-84, human, recombinant(1st International Standard) 95/646
            Lupus Anticoagulant Negative Control 96/522
            Anti-Human Globulin 96/666
            Prostate Specific Antigen (free) 96/668
            Prostate Specific Antigen (90:10) 96/670
            Islet Cell Antibodies 97/550
            Anti-Hepatitis A Immunoglobulin, Human (W1041) 97/646
            HIV-1 RNA, 2nd International Standard 97/650
            Prolactin, Human, recombinant 97/714
            Hepatitis B Virus DNA for nucleic acid amplification techniques 97/750
            Prolactin Human, recombinant, glycosylated 98/580
            Prolactin, Human, recombinant, non-glycosylated 98/582
            Haemiglobincyanide 98/708
            HIV-1 RNA Working Reagent 1 (PWS-1) for NAT Assays 99/634-005
            HIV-1 RNA Working Reagent 2 for NAT assays 99/636-005
            Chorionic Gonadotrophin, nicked, human 99/642
            Chorionic Gonadotrophin, beta subunit, human 99/650
            Anti-HPA-5b (Minimum Potency) 99/666
            HIV-2 (antibody) Monitor Sample 99/674-010
            Chorionic Gonadatrophin, intact, Human 99/688
            Chorionic Gonadotrophin, nicked beta subunit, Human 99/692
            Chorionic Gonadatrophin, beta core fragment, Human 99/708
            HIV-1 (antibody) (1 in 5 dilution) British Working Standard 99/710-012
            Chorionic Gonadotrophin, alpha subunit, Human (purified) 99/720
            Multiplex Working Reagent (HCV, HBV, HAV, HIV, B19) 99/732
            Parvovirus B19 DNA Working reagent 99/736
            HIV-1 (antibody) British Working Standard) 99/750-013
            B19 DNA NAT assays.2nd I.S. 99/802
            Anti-D Minimum Potency Standard for blood grouping reagents 99/836
            Alpha-Foetoprotein AFP
            Beta-2 Microglobulin B2M
            Anti-Canine Distemper Serum CDS
            Cholera Antitoxin, Goat CHAN
            Anti-Canine Hepatitis Serum CHS
            Anti-Dysentery (shiga) serum, Equine DY
            Anti-Echinococcus Serum, Human ECHS
            Anti-Mycoplasma gallisepticum Serum MGDS
            Anti-Newcastle Disease Serum NDS
            Anti-Q Fever Serum, Bovine QF
            Anti-rabies Immunoglobulin, Human RAI
            Swine Erysipelas Serum (anti-N) SES
            Anti-Swine Fever Serum SFS
            Anti-Salmonella Pullorum Serum (Std. Form S) SPDS-S2
            Anti-Salmonella Pullorum Serum (Variant Form V) SPDS-V
            Anti-tick borne encephalitis serum TILI
            Anti-tick borne encephalitis serum TISA
            Anti-C complete blood typing serum,human W1004
            Anti-E complete blood typing serum, human W1005
            Anti-c Incomplete blood typing serum, human W1007
            Anti-Varicella zoster immunoglobulin W1044
            Anti smooth muscle(anti actin) autoantibody. W1062
            Anti nuclear ribonucleoprotein(nRNP) autoantibody W1063
            Anti-Nuclear factor serum,homogenous(66/233) W1064
            Rheumatoid Arthritis serum. W1066


            Vaccines
            MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation) 00/410
            MAPREC assay of poliovirus type 1 (Sabin) Low Mutant Virus Reference(1st International Reference Preparation) 00/416
            MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard) 00/418
            MAPREC assay of poliovirus type 1 (Sabin) High Mutant Virus Reference(1st International Reference Preparation) 00/422
            Influenza anti A/Singapore/1/57 Serum (sheep) H2 00/440
            Influenza anti B/Yamanashi/166/98 Serum (sheep) 00/442
            Diphtheria Antitoxin Human Serum 00/496
            Botulinum Antitoxin Human 00/500
            Influenza Virus infectious B/Sichuan/379/99 00/530
            Influenza Virus infectious B/Johannesburg/5/99 00/532
            Influenza anti A/Chick/Scotland/59 (H5N1) Serum (sheep) 00/542
            Influenza Virus infectious B/Victoria/504/00 00/544
            Influenza Antigen B/Johannesburg/5/99 00/546
            Influenza Antigen A/duck/Singapore/97 (H5N3) 00/552
            Influenza anti B/Johannesburg/5/99/ Serum (sheep) 00/556
            Influenza Virus infectious B/Guangdong/120/00 00/614
            Anti-Meningococcal immunotype L3,7,9 mAb 01/412
            Meningococcal group Y polysaccharide 01/426
            Meningococcal group W135 polysaccharide 01/428
            Influenza anti B/Guangdong/120/2000 Serum (sheep) 01/450
            Influenza anti A/Panama/2007/99 Serum (sheep) 01/452
            Botulinum Antitoxin Equine Type F 01/506
            Botulinum Antitoxin Equine Type C 01/508
            Botulinum Antitoxin Equine Type G 01/512
            Anti-Meningococcal Serosubtype P1.7 mAb 01/514
            Oral Poliovaccine Sabin Reference Preparation Type 1[LS-c, 2ab strain] 01/528
            Oral Poliovaccine Sabin Reference Preparation Type 2 01/530
            Oral Poliovaccine Sabin Reference Preparation Type 3 01/532
            Anti-Meningococcal Serosubtype P1.16 mAb 01/538
            Influenza Antigen B/Guangdong/120/2000 01/546
            Influenza Virus infectious B/Hawaii/10/01 01/612
            Influenza Antigen A/New Caledonia/20/99 01/614
            Influenza anti A/Panama/2007/99 Serum (sheep) 02/102
            Anti-Meningococcal Serosubtype P1.15 mAb 02/144
            Anti-Meningococcal Serosubtype P1.4 mAb 02/148
            Diphtheria Toxoid for use in Flocculation Test. 02/176
            Anti-Meningococcal Serosubtype P1.2 mAb 02/178
            Anti-Meningococcal Serotype P2.2a mAb 02/180
            Anti-Japanese Encephalitis Virus Plasma, Human 02/182
            Anti-Japanese Encephalitis (Anti-JE) Virus Control Plasma, Human 02/184
            Anti-Dengue Virus Types 1+2+3+4, Human 02/186
            Haemophilus influenzae b PRP 02/208
            Tetanus Toxoid Not Adsorbed 02/232
            Influenza Virus infectious B/Brisbane/32/2002 02/262
            Influenza anti A/chick/Italy/13474/99 (H7N1) Serum (sheep) 02/294
            Polio Virus Sabin Types 1, 2 and 3 02/306
            Anti-Meningococcal Serotype P3.4 mAb 02/308
            Anti-Meningococcal Serotype P3.15 mAb 02/310
            Botulinum Antitoxin Equine Type E 02/318
            Anti-Meningococcal Serosubtype P1.3 mAb 02/320
            Influenza Antigen A/New Caledonia/20/99 02/336
            Influenza anti A/Panama/2007/99 Serum (sheep) 02/338
            Influenza anti B/Shangdong/9/97 Serum (sheep) 03/110
            Anti-Meningococcal Serosutype P1.1 mAb 03/114
            Anti-Meningococcal Serosubtype P1.14 mAb 03/142
            Anti-Meningococcal Serotype P3.21 mAb 03/182
            Influenza Virus infectious A/Kumamoto/102/02 03/198
            Anti-Meningiococcal Serosubtype P1.6 mAb 03/210
            Influenza anti A/Wyoming/03/03 Serum 03/212
            Influenza Antigen A/Wyoming/03/03 03/220
            Anti-Meningococcal Serosubtype P1.10 mAb 03/224
            Anti-Meningococcal Serosubtype P1.5 mAb 03/226
            Anti-Meningococcal Serosubtype P1.13 mAb 03/236
            Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum 03/242
            Influenza anti A/chick/Germany/N/49 (H10N7) HA Serum (sheep) 03/244
            Influenza Antigen A/New Caledonia/20/99 (IVR-116) 03/258
            Anti-Meningococcal Serosubtype P1.12 mAb 04/122
            Tetanus Toxoid For Flocculation Test 04/150
            Influenza Virus infectious NYMC X-147 04/160
            Influenza Virus infectious A/Wellington/1/2004 04/170
            Influenza Virus infectious IVR-139 04/172
            Anti-Meningococcal Serotype P3.1 mAb 04/198
            Influenza Antigen B/ Jiangsu/10/2003 04/202
            Influenza anti A/Vietnam/1194/04 (NIBRG-14) HA Serum (sheep SH440&SH442) 04/214
            Influenza anti B/ Neuraminidase Serum 04/228
            Influenza anti N1 Neuraminidase Serum 04/230
            Influenza anti B/Jiangsu/10/2003 HA Serum (sheep) 04/242
            Anti-Meningococcal Serogroup W-135 mAb 04/246
            Anti-Meningococcal Serosubtype P1.19 mAb 04/248
            Influenza Virus infectious A/New York/55/2004 04/254
            Influenza anti N2 Neuraminidase Serum(prepared from A/Wyoming/3/2003) 04/258
            Influenza anti A/New Caledonia/20/99 HA Serum (sheep) 04/260
            Influenza anti A/New York/55/2004 HA Serum (sheep) 04/262
            Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157) 04/264
            Influenza Virus infectious NYMC BX-7 05/102
            Influenza Virus infectious A/California/7/2004 05/110
            Anti-human papillomavirus type 16 serum (1st International Standard) 05/134
            Influenza Virus infectious B/Shanghai/361/2002 05/138
            Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody 05/190
            Anti Meningococcal Serotype P2.2b Monoclonal Antibody 05/192
            Influenza Virus infectious A/Hiroshima/52/2005 05/232
            Influenza Antigen A/Wisconsin/67/2005 - Like 05/234
            Influenza anti A/Wisconsin/67/2005 Serum (sheep) 05/236
            Influenza Virus infectious NYMC X-161 05/244
            Anti Dengue, WHO Reference Panel 05/248
            Influenza anti B Neuraminidase Serum (Sheep SH463) 05/252
            Influenza Antigen A/Wisconsin/67/2005 (H3N2) (NYMCX-161) 06/106
            Influenza Virus infectious IVR-116 06/108
            Influenza Virus Infectious A/PR/8/34 06/114
            Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 2 (1st International Standard) 06/124
            Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 3 (1st International Standard) 06/128
            Pertussis Antiserum (human)1st IS - WHO international Standard. 06/140
            Pertussis Antiserum (Human) 1st WHO Reference Reagent 06/142
            Influenza Virus infectious 1 VR-142 06/164
            Influenza Antigen A/New Caledonia/20/99 06/170
            Influenza Virus infectious A/Wisconsin/67/2005 06/184
            Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466) 06/192
            Medium Titre Meningococcal OMV Ref. serum 06/210
            Influenza Virus infectious A/Solomon Islands/3/2006 07/132 06/236
            Influenza Virus infectious NYMC-X161 B 06/242
            Influenza Antigen A/Solomon Islands/3/2006 (IVR-145)(H1N1) 07/102
            Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum (sheep 467,468,469,470) 07/104
            Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 07/112
            Influenza Virus infectious B/Malaysia/2506/2004 07/132
            Influenza Virus infectious IVR-145, 07/144
            Influenza anti A/HongKong/1073/99 like HA Serum (sheep) 07/146
            Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum 07/148
            Human Plasma Anti-Influenza H5N1 07/150
            Rabies vaccine 07/162
            Influenza anti B/Malaysia/2506/2004-HA Serum (sheep) 07/184
            Diphtheria Toxoid (Adsorbed) (4th International Standard) 07/216
            Influenza Virus Infectious A/New Caledonia/20/99 07/226
            Influenza Virus Infectious IVR-147 07/246
            Influenza Virus infectious NIBRG-14 07/252
            Influenza Virus Infectious B/Brisbane/3/2007 07/268
            BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent) 07/270
            BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent) 07/272
            BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) 07/274
            Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475) 07/278
            Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6 07/290
            Meningococcal Group C Polysaccharide 07/318
            Influenza Antigen A/mallard/Netherlands/12/00 (H7N3) NIBRG-60 07/336
            Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (Sheep SH477) 07/338
            Influenza Virus infectious NYMC X-171B 07/348
            Influenza Virus infectious A/Uruguay/716/2007 07/354
            Influenza Anti-B/Florida/4/2006 HA serum (sheep 478, 479) 07/356
            Influenza Virus infectious NIB-50 07/358
            Influenza Virus infectious IVR-149 07/362
            Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1) 08/100
            Influenza Virus Infectious NIBRG-91 08/108
            Influenza Virus Infectious NIBRG-88 08/110
            Influenza anti A/turkey/Turkey/1/05(N1) NA Serum (NIBRG-74) (Sheep SH485) 08/126
            Influenza Virus Infectious B/Florida/4/2006 08/138
            Influenza Antigen B/Florida/4/2006 08/140
            Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (sheep SH477) 08/142
            Influenza Virus Infectious NIBRG-12 08/154
            Influenza Virus Infectious NIBRG-23 30060 VE3 08/156
            Influenza Antigen B/Malaysia/2506/2004 08/184
            Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1) 08/202
            Influenza Antigen Hong Kong/1073/99 (H9N2) 08/208
            Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86) 08/210
            Influenza Antigen A/Cambodia/R0405050/2007 (H5N1) NIBRG-88 08/216
            Tetanus Toxoid Adsorbed (4th International Standard) 08/218
            Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91 08/228
            Influenza anti A/Brisbane/10/2007- like HA serum 08/246
            Influenza Antigen A/mallard/England/727/2006 (H2N3) NIBRG-107 08/268
            Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C)) 08/278
            Influenza Virus Infectious B/Brisbane/33/2008 08/280
            Influenza Virus Infectious IVR-148 08/300
            Influenza virus infectious NYMC X-175C 08/304
            Influenza Antigen B/Brisbane/60/2008-like 08/352
            Influenza anti A/Japan/305/57 (H2) HA serum (A/Singapore/1/57-Like) (Sheep SH398) 08/356
            Influenza Virus Infectious BX-31 08/360
            Influenza Antigen A/New York/107/2003 (H7N2) NIBRG-109 08/362
            Influenza Virus Infectious NIB-58 08/364
            Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503) 09/100
            Influenza Virus Infectious NIBRG-122 09/130
            Influenza Antigen A/California/7/2009 (H1N1)v (NYMC-179A) (Egg derived) 09/146
            Clostridium Sordellii anti-serum (1st International standard) 09/154
            Influenza Virus Infectious B/Brisbane/60/2008 09/168
            Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody 09/170
            Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A) (Cell Derived) 09/174
            Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14 09/184
            Influenza Antibody (human) to A/California/7/2009 "like" (H1N1v) (1st International Standard) 09/194
            Influenza Antigen A/California/7/2009 (H1N1v) (NIBRG-121xp) (Egg Derived) 09/196
            Diphtheria Antitoxin Equine DI 09 10 iu/ml 09/204
            Influenza Virus Infectious A/Perth/16/2009 09/208
            Influenza Virus Infectious NYMC X-179A 09/216
            Influenza Virus Infectious IVR-153 09/236
            Influenza Virus Infectious NYMC X-183 09/248
            Influenza Virus Infectious NIBRG-121xp 09/268
            Influenza Virus Infectious NYMC X-185 09/274
            Influenza Virus Infectious A/Brisbane/59/2007 09/276
            Influenza Virus Infectious NIB-64 09/280
            Influenza Virus Infectious NYMC X-187 09/290
            Influenza Antigen A/California/7/09 (H1N1)v (NYMC-181) (Egg Derived) 09/294
            Influenza Virus Infectious IVR-155 09/304
            Influenza Virus Infectious NIBRG-147 09/306
            Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183) 09/310
            Influenza Virus Infectious NYMC X-181 09/314
            Influenza Anti B Neuraminidase Serum (B/Florida/4/2006) 09/316
            Influenza Virus Infectious NYMC BX-35 09/318
            Influenza Antigen A/Victoria/210/09 (H3N2) (NYMCX-187) 10/102
            Influenza Antigen B/Brisbane/60/2008 Reassortant (NYMC BX-35) 10/106
            Influenza Antiserum A/Brisbane/59/2007 (H1N1)(IVR-148) HA (sheep 516 and 517) 10/120
            Influenza Virus Infectious A/California/7/2009 10/122
            Diphtheria Polyclonal Antibody 10/128
            Diphtheria Monoclonal Antibody 10/130
            Tetanus Polyclonal Antibody 10/132
            Tetanus Monoclonal Antibody 10/134
            Influenza Anti-B/Brisbane/60/2008 HA serum 10/146
            Influenza Anti-A/Perth/16/2009 HA Serum 10/182
            Influenza Anti A/Hong Kong 1073/99 (N2)NA Serum (Sheep SH395 SH396) 10/214
            Influenza Virus Infectious NIB-74 10/216
            Influenza Anti A/California/7/2009 (N1) NA Serum (Sheep SH 521) 10/218
            Influenza Virus Infectious IVR-158 10/226
            Influenza Anti-A/California/7/2009 (H1N1) HA Serum 10/230
            Influenza virus infectious B/Brisbane/60/2008 30990 E6 10/244
            Clostridium Perfringens Beta Antitoxin 2CPBETAAT
            Clostridium Perfringens Epsilon Antitoxin 2CPEPSILONAT
            Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine 59/015
            Botulinum Antitoxin Equine Type A 59/021
            Botulinum Antitoxin Equine Type B 60/001
            Tetanus Antitoxin, Equine, for Bioassay 60/013
            Botulinum Antitoxin Equine Type D 61/001
            Gas Gangrene Antitoxin (Cl. Histolyticum), Equine 63/005
            Diphtheria Antitoxin, Equine, for Flocculation Test 63/007
            Gas Gangrene Antitoxin (Cl. Septicum), Equine 64/014
            Gas Gangrene Antitoxin (Cl. Oedematiens), Equine 64/024
            Tetanus Antitoxin, Equine, for Flocculation Test 66/021
            Diphtheria Antitoxin, Equine 66/153
            Anti-Rubella Serum, Human 67/182
            Diphtheria Toxoid, Plain 69/017
            Cholera Vaccine (Inaba) 73/554
            Opacity 5IRP 76/522
            Influenza anti A/Victoria/3/75 Serum(goat) 76/547
            Tetanus Antitoxin, Human, Immunoglobulin 76/589
            Influenza Antigen A/New Jersey/8/76 77/530
            Influenza anti A/New Jersey/8/76 (H1N1) Serum(sheep) 77/531
            Influenza anti B/Hong Kong/8/73 Serum(sheep) 77/568
            Influenza Antigen A/Texas/1/77 78/560
            Influenza anti A/Texas/1/77 Serum (sheep) 78/569
            Influenza anti A/Brazil/11/78 Serum (goat) 79/516
            Influenza Antigen A/USSR/92/77 79/552
            Influenza Antigen A/USSR/92/77 79/558
            Influenza Antigen A/Brazil/11/78 79/560
            Influenza Antigen B/Hong Kong/8/73 79/568
            Influenza Antigen A/Bangkok/1/79 80/517
            Influenza Antigen B/Singapore/222/79 80/519
            Influenza anti B/Singapore/222/79 Serum 80/523
            Influenza anti A/Bangkok/1/79 Serum (sheep) 80/525
            Anti Poliovirus serum types 1,2 and 3 82/585
            Influenza Antigen A/Philippines/2/82 83/537
            Influenza anti A/Philippine/2/82 Serum (sheep) 83/545
            Influenza Antigen A/Brazil/11/78 83/550
            Influenza Antigen A/Chile/1/83 84/538
            Influenza Antigen B/Norway/1/84 84/542
            Influenza anti B/USSR/100/83 Serum(sheep) 84/636
            Influenza anti A/Chile/1/8 Serum(sheep) 84/640
            Influenza anti A/equine/Prague/56 (H7N7) Serum(goat) 84/673
            Influenza anti A/equine/Miami/63 (H3N8) Serum(goat) 84/677
            Influenza anti A/Equine/Kentucky/1/81 HA Serum (sheep) 85/516
            Influenza Antigen A/Equine/Kentucky/1/81 85/520
            Influenza Antigen A/Equine/Prague/56 (H7N7) 85/553
            Influenza Antigen A/Mississippi/1/85 86/576
            Influenza anti A/Mississippi/1/85 Serum(sheep) 86/590
            Influenza anti B/Ann Arbor/1/86/HA Serum (sheep) 86/592
            Influenza Antigen B/Ann Arbor/1/86 86/630
            Influenza Antigen A/Equine/Miami/63 87/510
            Influenza anti A/Leningrad/360/86 Serum (sheep) 87/578
            Influenza Antigen A/Leningrad/360/86 87/584
            Influenza Antigen A/Sichuan/2/87 87/714
            Influenza Antigen B/Victoria/2/87 87/774
            Bordela pertussis (Whole cell vaccine) 3BRP 88/522
            Influenza Antigen B/Beijing/7/87 88/554
            Influenza Antigen A/England/427/88 88/654
            Influenza anti A/Sichuan/2/87 Serum(sheep) 88/672
            Influenza anti B/Beijing/1/87 Serum(sheep) 88/678
            Influenza anti A/England/427/88 Serum(sheep) 88/846
            Anti-Bordela pertussis serum (Human) 89/530
            Influenza Antigen A/OMS/5389/88 89/568
            Bordela pertussis (W28) LPS 2ug 89/594
            Bordela pertussis anti-agglutinogen 1(rabbit) 89/596
            Bordela pertussis anti-agglutinogen 2 (rabbit) 89/598
            Bordela pertussis anti-agglutinogen 3 (rabbit) 89/600
            Bordela pertussis (W28) LPS25ug 89/670
            Influenza Antigen A/Shanghai/16/89 90/500
            Influenza Antigen A/Guizhou/54/89 90/502
            Influenza anti A/Guangdong/39/89 Serum(sheep) 90/504
            Bordela Pertussis toxin (PT) 90/518
            Bordela pertussis, filamentous haemagglutinin (FHA) 90/520
            Mumps Vaccine (Live) 90/534
            Bordela pertussis 69kD 90/654
            Influenza Virus infectious NIB-26 (H3N2) 90/784
            Poliomyelitis Vaccine (Inactivated) 91/574
            Influenza anti A/Taiwan/1/86 Serum (sheep) 91/612
            Influenza Virus infectious A/Texas/36/91 (H1N1) 91/660
            Influenza Virus infectious NIB-27 (H1N1) 91/670
            Rubella Vaccine (Live) 91/688
            Influenza Antigen A/Texas/36/91 92/530
            Influenza anti B/Yamagata/16/88 Serum(sheep) 92/582
            Influenza Antigen B/Yamagata/16/88 92/628
            Influenza anti A/Beijing/352/89 (H3N2) Serum (sheep) 92/632
            Measles Vaccine (Live) 92/648
            Influenza Virus infectious A/Beijing/32/92 (H3N2) 92/734
            Influenza Virus infectious A/Shanghai/24/90 92/738
            Influenza Antigen A/Beijing/32/92 93/500
            Influenza Antigen A/Shanghai/24/90 93/516
            Influenza anti A/Beijing/32/92 (H3N2) Serum (sheep) 93/518
            Influenza anti A/Shanghai/24/90 (H3N2) Serum (sheep) 93/522
            Influenza Virus infectious A/Beijing/359/89 (H3N2) 93/568
            Influenza Virus infectious A/Guizhou/54/89 (H3N2) 93/572
            Influenza Virus infectious A/Shangdong/9/93 (H3N2) 93/686
            Influenza Virus infectious B/Panama/45/90 93/692
            Influenza Virus infectious A/Harbin/15/92 (H3N2) 93/816
            Influenza Antigen B/Panama/45/90 94/500
            Influenza anti A/Shanghai/9/93 Serum(sheep) 94/504
            Influenza Antigen A/Shangdong/9/93 94/516
            Influenza anti B/Panama/45/90 Serum(sheep) 94/520
            Pertussis Vaccine Whole Cell 94/532
            Influenza Virus infectious A/Johannesburg/33/94 (H3N2) 94/758
            Influenza Virus infectious B/Beijing/184/93 94/760
            Influenza Virus infectious RESVIR-8 (H3N2) 94/762
            Influenza Virus infectious NIB-34 (H3N2) 94/766
            MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C 94/790
            Hepatitis A Vaccine, inactivated 95/500
            Influenza Antigen A/Texas/36/91 95/510
            Influenza Antigen A/Johannesburg/33/94 95/516
            Influenza anti A/Johannesburg/33/94 Serum(sheep) 95/524
            Influenza anti A/Taiwan/1/86 Serum (H1N1) 95/536
            MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C 95/542
            Anti-Meningococcal Serogroup A mAb 95/674
            Anti-Meningococcal Serogroup C mAb 95/678
            Anti-Meningococcal Serogroup B mAb 95/750
            Influenza Virus infectious A/Wuhan/359/95 (H3N2) 95/758
            Anti-Hib Human Reference Serum 96/536
            MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C 96/572
            MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C 96/578
            Influenza Virus infectious A/Bayern/7/95 96/830
            Influenza Virus infectious RESVIR-9 (H3N2) 96/836
            Influenza Virus infectious A/Shenzhen/227/95 (H1N1) 96/848
            Influenza Virus infectious NIB-39 (H1N1) 96/850
            Influenza Antigen A/Johannesburg/82/96 97/518
            Bordela pertussis anti 69kD serum (sheep) 97/558
            Bordela pertussis anti FHA serum (sheep) 97/564
            Bordela pertussis PT anti serum (sheep) 97/572
            Bordela pertussis anti Fim3 serum (sheep) 97/574
            Influenza Antigen A/Equine/Newmarket/2/93 97/584
            Influenza Antigen A/Equine/Newmarket/1/93 97/596
            Influenza anti A/equine/Newmarket/1/93 Serum(sheep) 97/610
            Influenza anti A/Nanchang/933/95 (H3N2) 97/612
            Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376) 97/614
            Bordela pertussis anti serum (mouse) 1RR 97/642
            Anti-Measles serum 97/648
            AntiStreptolysin O 97/662
            Influenza Virus infectious IVR-108 (H3N2) 97/692
            Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3) 97/722
            Influenza Virus infectious B/Harbin/7/94 97/726
            Influenza Antigen B/Harbin/7/94 97/748
            MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G 97/756
            MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G 97/758
            Influenza Antigen A/Beijing/262/95 97/760
            MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G 98/524
            Influenza Virus infectious RESVIR-13 (H3N2) 98/544
            Diphtheria and Tetanus Antitoxin, Guinea Pig Serum 98/572
            MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G 98/596
            Influenza Virus infectious NIB-40 (H5N3) 98/600
            Influenza anti B/Harbin/7/94/HA Serum (sheep) 98/604
            Influenza Virus infectious ARIV-1 (H5N3) 98/610
            Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep) 98/666
            Control Guinea Pig Serum 98/686
            Meningococcal group A polysaccharide 98/722
            Influenza Virus infectious Resvir-14 (H3N2) 98/762
            Influenza anti A/Beijing/262/95 Serum (sheep) 98/772
            Influenza Antigen B/Shangdong/7/97 98/774
            Influenza Virus infectious A/Sichuan/346/98 (H3N2) 98/778
            Anti-PT S1 subunit Monoclonal Antibody (1B7) 99/506
            Anti-PT S1 subunit Monoclonal Antibody (1D7) 99/508
            Anti-PT S1 subunit Monoclonal Antibody (3F11) 99/510
            Anti-PT S1 subunit Monoclonal Antibody (10D6) 99/512
            Anti-PT S1 subunit Monoclonal Antibody (8G4) 99/514
            Anti-PT S1 subunit Monoclonal Antibody (E1E) 99/516
            Anti-PT S1 subunit Monoclonal Antibody (E2E) 99/518
            Anti-PT S1subunit Monoclonal Antibody (3F10) 99/520
            Anti-PT S1 subunit Monoclonal Antibody (11D9) 99/522
            Anti-PT S1 subunit Monoclonal Antibody (4D10) 99/524
            Anti-PT S23 subunit Monoclonal Antibody (11E6) 99/526
            Anti-PT S23 subunit Monoclonal Antibody (10C9) 99/528
            Anti-PT S23 subunit Monoclonal Antibody (10B5) 99/530
            Anti-PT S23 subunit Monoclonal Antibody (G9A) 99/532
            Anti-PT S23 subunit Monoclonal Antibody (3F6) 99/534
            Anti-PT S2 subunit Monoclonal Antibody (3A12) 99/536
            Anti-PT S2 subunit Monoclonal Antibody (2H3) 99/538
            Anti-PT S2 subunit Monoclonal Antibody (9G8) 99/540
            Anti-PT S3 subunit Monoclonal Antibody (7E10) 99/542
            Anti-PT S3 subunit Monoclonal Antibody (7G11) 99/544
            Anti-PT S3 subunit Monoclonal Antibody (4G5) 99/546
            Anti-PT S3 subunit Monoclonal Antibody (2E12) 99/548
            Anti-PT S3 subunit Monoclonal Antibody (6F8) 99/550
            Anti-PT S4 subunit Monoclonal Antibody (7F2) 99/554
            Anti-PT S4 subunit Monoclonal Antibody (6B3) 99/556
            Anti-PT S4 subunit Monoclonal Antibody (6G8) 99/558
            Anti-PT S4 subunit Monoclonal Antibody (9F3) 99/560
            Anti-PT S4 subunit Monoclonal Antibody (1H2) 99/562
            Anti-PT S4 subunit Monoclonal Antibody (9C6) 99/564
            Anti-PT S4 subunit Monoclonal Antibody (6D6) 99/566
            Anti-PT S5 subunit Monoclonal Antibody (7E3) 99/568
            Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6) 99/570
            Anti-Filamentous haemagglutinin Monoclonal Antibody (2E9) 99/572
            Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10) 99/574
            Influenza Antigen B/Yamanashi/166/98 99/586
            Methylated Human Serum Albumin (mHSA) 99/592
            Influenza Antigen A/Sydney/5/97 99/614
            Yellow Fever Vaccine 99/616
            Influenza Antigen A/Sydney/5/97 99/624
            Anti-Meningococcal human reference serum CDC1992 99/706
            Influenza Antigen A/Singapore/1/57 (H2N2) 99/714
            Influenza Virus infectious RESVIR 16 (H3N2) 99/824
            Influenza Antigen B/Yamanashi/166/98 99/828
            Botulinum Antitoxin Equine Type B BUSB
            Clostridium novyi (alpha) Toxoid COT
            Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT CWBETATD
            Clostridium Welchii (Perfringens)( Epsilon) Toxoid CwDT CWEPSILONTD
            Bordela pertussis anti FHA serum (mouse) JNIH-11
            Bordela pertussis PT( LPF) anti serum, (mouse) JNIH-12
            Acellular Pertussis Vaccine - 1st IS JNIH-3
            Bordela pertussis filamentous haemagglutinin (FHA) JNIH-4
            Bordela pertussis toxin (PT) 1st IS JNIH-5
            Newcastle Disease Vaccine (Inactivated) NVIA
            Gas Gangrene Antitoxin (Cl. novyi), Equine OE
            Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine PE
            Purified Protein Derivative (PPD) of M Avium Tuberculin PPDA
            Purified Protein Derivative (PPD) of Bovine Tuberculin PPDBOV
            Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin PPDT
            Anti-rubella Immunoglobulin, Human RUBI-1-94
            Smallpox Vaccine SMV
            Anti-Staphylococcal P-V Leucocidin serum, Equine SPLS
            Staphylococcus Alpha Antitoxin, Equine STA
            Diphtheria (Schick) Test Toxin STT
            Tetanus Immunoglobulin, Human TE-3
            Typhoid Vaccine (acetone-inactivated) TYVK
            Typhoid Vaccine (heat-phenol-inactivated) TYVL
            Gas Gangrene Antitoxin (Cl. Septicum), Equine VI
            Anti-Yellow Fever Serum, monkey YF

                
            留言框
            感興趣的產(chǎn)品: *
            留言內(nèi)容:
            您的姓名: *
            您的單位:
            聯(lián)系電話: *
            微信:
            常用郵箱:
            詳細(xì)地址:
            省份: *
            驗(yàn)證碼: * =   請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
                  
            產(chǎn)品搜索

            請(qǐng)輸入產(chǎn)品關(guān)鍵字:

            聯(lián)系方式
            地址:上海浦東川沙鎮(zhèn)川沙路6619號(hào)上海起發(fā)實(shí)驗(yàn)試劑有限公司
            郵編:201203
            聯(lián)系人:楊經(jīng)理
            電話:021-50724187 021-50724961
            傳真:021-50724961
            手機(jī):15921799099
            留言:發(fā)送留言
            個(gè)性化:www.qfbio.com
            網(wǎng)址:www.qfbio.com
            商鋪:http://apwanrong.com/st178406/
            | 商鋪首頁 | 公司檔案 | 產(chǎn)品展示 | 供應(yīng)信息 | 公司動(dòng)態(tài) | 詢價(jià)留言 | 聯(lián)系我們 | 會(huì)員管理 |
            化工儀器網(wǎng) 設(shè)計(jì)制作,未經(jīng)允許翻錄必究.Copyright(C) http://apwanrong.com, All rights reserved.
            以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
            溫馨提示:為規(guī)避購買風(fēng)險(xiǎn),建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。
            二維碼 在線交流

            掃一掃訪問手機(jī)站